IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BB Biotech AG

Q2 2017 Holdings

Filed 2017-08-11 | 28 holdings | $248.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Agios Pharmaceuticals Inc.(AGIO)COM00847X104$147.6M2,869,52859.5%
Alnylam Pharmaceuticals Inc.(ALNY)COM02043Q107$97.4M1,221,33839.3%
Incyte Corp.(INCY)COM45337C102$442.6K3,514,8220.2%
Celgene Corp(CELG)COM151020104$422.0K3,249,2980.2%
Ionis Pharmaceuticals Inc.(IONS)COM462222100$374.1K7,354,0950.2%
Radius Health Inc.COM750469207$227.9K5,038,7990.1%
Gilead Sciences Inc.(GILD)COM375558103$196.4K2,774,5960.1%
Vertex Pharmaceuticals Inc.(VRTX)COM92532F100$190.1K1,475,4450.1%
Alexion Pharmaceuticals Inc.(ALXN)COM015351109$164.8K1,354,4280.1%
Neurocrine Biosciences Inc.(NBIX)COM64125C109$158.5K3,446,5520.1%
Tesaro Inc.COM881569107$122.8K877,9900.0%
Halozyme Therapeutics Inc.(HALO)COM40637H109$106.0K8,265,3040.0%
Regeneron Pharmaceuticals Inc.(REGN)COM75886F107$88.4K180,0000.0%
Sage Therapeutics Inc.(SG7)COM78667J108$72.3K907,4390.0%
Esperion Therapeutics Inc.(ESPR)COM29664W105$70.0K1,513,5420.0%
Kite Pharma Inc.COM49803L109$66.3K640,0000.0%
Juno Therapeutics Inc.COM48205A109$65.3K2,185,0000.0%
MacroGenics Inc.(MGNX)COM556099109$41.2K2,350,1120.0%
Myovant Sciences Ltd.COMG637AM102$38.8K3,317,1710.0%
AveXis, Inc.COM05366U100$33.1K402,8000.0%
Intercept Pharmaceuticals Inc.(ICPTUSD)COM45845P108$31.0K255,7190.0%
Intra-Cellular Therapies Inc.(ITCIEUR)COM46116X101$26.7K2,150,0000.0%
Five Prime Therapeutics Inc.(FPRX)COM33830X104$23.4K777,5000.0%
Alder Biopharmaceuticals Inc.(ALDR1EUR)COM014339105$22.2K1,941,0080.0%
Prothena Corp. PLC(PRTA)COMG72800108$18.9K350,0000.0%
Novavax Inc.COM670002104$9.6K8,330,0000.0%
Cidara Therapeutics Inc.COM171757107$8.3K1,102,5780.0%
Achillion Pharmaceuticals Inc.(ACHNEUR)COM00448Q201$5.9K1,279,3400.0%